Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The luxCDABE operon is a genetic cluster primarily found in bioluminescent marine and terrestrial bacteria, such as Aliivibrio fischeri and Photorhabdus luminescens, that enables the production of visible blue-green light. It is a unique system because it encodes both the luciferase enzyme (LuxAB) and the enzymes required to synthesize its aldehyde substrate (LuxCDE), allowing for completely autonomous bioluminescence in host organisms (Winson, M. K., et al., 1998). The light-emitting reaction involves the oxidation of reduced flavin mononucleotide and a long-chain fatty aldehyde, a process that is highly dependent on the metabolic state of the cell. While not a direct therapeutic target for treating human diseases, the operon is an invaluable tool in drug discovery and microbiology, serving as a real-time reporter for monitoring gene expression, bacterial viability, and antibiotic efficacy (Francis, K. P., et al., 2000). In pharmaceutical research, it is frequently used to engineer 'bioluminescent' pathogens, enabling non-invasive imaging of infection progression and the evaluation of antimicrobial treatments in living animal models.
The luxCDABE operon encodes the enzymes necessary for bacterial bioluminescence. The luxA and luxB genes encode the alpha and beta subunits of luciferase, which catalyzes the oxidation of reduced flavin mononucleotide (FMNH2) and a long-chain aldehyde (tetradecanal). The luxC, luxD, and luxE genes encode a fatty acid reductase complex (reductase, transferase, and synthetase) that continuously regenerates the aldehyde substrate from fatty acids, allowing for autonomous light emission without the addition of external substrates (Meighen, E. A., 1991; Close, D. M., et al., 2012).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial luciferase operon (luxCDABE) (luxCDABE).